Loading clinical trials...
Loading clinical trials...
Effects Of Pulsatile and Non-Pulsatile Cardiopulmonary Bypass Flow On Predictors Of Outcome After Coronary Artery Bypass Graft Surgery
In cardiac operations, high values of blood lactate have been associated with bad outcomes if detected both during CPB and at the arrival in the intensive care unit (ICU) in adult patients. Many studies highlighted the potential role of hyperlactatemia on admission to the ICU as a marker for adverse outcome, and one study linked hyperlactatemia during CPB with postoperative morbidity and mortality. Evidence that both CENTRAL VENOUS SATURATION (ScVO2) and blood lactates during CPB are potential early predictors of morbidity and mortality in adult cardiac operations are still lacking.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Start Date
July 1, 2025
Primary Completion Date
November 1, 2025
Completion Date
December 1, 2025
Last Updated
June 24, 2025
60
ESTIMATED participants
CORONARY BYPASS SURGERY USING CARDIOPULMONARY BYPASS
PROCEDURE
cardiac surgical patients who will undergo isolated elective cardiopulmonary bypass
PROCEDURE
Lead Sponsor
Alexandria University
NCT05573633
NCT07418242
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07287345